Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A patient lost all their hair while on rheumatoid arthritis medication.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Upadacitinib and narrowband UVB effectively treated a child's vitiligo and alopecia areata.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Asparagus racemosus and Withania somnifera can help reduce side effects of a cancer drug.

GnRH treatment can reduce breast cancer cell invasion.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Mesotherapy can be beneficial but has risks if misused.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Entospletinib effectively prevents eye and skin GVHD in mice.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Tralokinumab successfully treated alopecia areata in a patient with atopic dermatitis.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.